OUR STRATEGY

Performance against Strategy

OUR STRATEGY

Performance against Strategy

human centred collections

Aspiration

  • Enhance donor experience through a human centred approach.
  • Enhance brand advocacy

Strategic Priorities

  • Increase capacity and capability to collect more blood
  • Determine true blood demand
  • Manage deferrals to acceptable levels through strategic initiatives
  • Ensure improved donor outcomes and excellence and deliver excellence in donor care
  • Focus on new donors, youth and black donors

FY22 Highlights

  • # of units Group O whole blood collected was below target; effects of C-19
  • # of units of Apheresis platelets collected exceeded target
  • Days’ cover exceeded target

Contribution to Long-term Sustainable Value

Related Material
Matters

  • Meeting blood demand
  • Future changing world

human centred collections

Aspiration

  • Enhance donor experience through a human centred approach.
  • Enhance brand advocacy

Strategic Priorities

  • Increase capacity and capability to collect more blood
  • Determine true blood demand
  • Manage deferrals to acceptable levels through strategic initiatives
  • Ensure improved donor outcomes and excellence and deliver excellence in donor care
  • Focus on new donors, youth and black donors

FY22 Highlights

  • # of units Group O whole blood collected was below target; effects of C-19
  • # of units of Apheresis platelets collected exceeded target
  • Days’ cover exceeded target

Contribution to Long-term Sustainable Value

Related Material
Matters

  • Meeting blood demand
  • Future changing world

Reflecting on our performance against the 2021/2022 Scorecard and how we added value

Target achieved/exceeded New initiative on track against current plan (no concerns Improvements YOY No Concerns yet Below Target

Reflecting on our performance against the 2021/2022 Scorecard and how we added value

Target achieved/exceeded New initiative on track against current plan (no concerns Improvements YOY No Concerns yet Below Target

Below, we further unpack the various components of our performance against our iHEALTh strategy

Key Measured Initiatives

Below, we further unpack the various components of our performance against our iHEALTh strategy

Key Measured Initiatives

% Deferrals from all donations

  • <15.0%

  • 10.5 %

  • 10.15%

  • <15.0%
  • Expanding donor base therefore deferrals increase

% Deferrals from all donations

  • <15.0%

  • 10.5 %

  • 10.15%

  • <15.0%
  • Expanding donor base therefore deferrals increase

% Hb Deferrals from all donations Consolidation of all deferrals

  • 7.5% or less

  • 5%

  • 4.9%

  • 7.5% or less

% Hb Deferrals from all donations Consolidation of all deferrals

  • 7.5% or less

  • 5%

  • 4.9%

  • 7.5% or less

#Ferritin testing - Roll out in Zones

  • Overall objective  is to reduce iron deficiency amongst donors

  • 2

  • Developed and implemented ferritin testing algorithms

  • Develop holistic  iron management programme for donors with low ferritin

#Ferritin testing - Roll out in Zones

  • Overall objective  is to reduce iron deficiency amongst donors

  • 2

  • Developed and implemented ferritin testing algorithms

  • Develop holistic  iron management programme for donors with low ferritin

No. of source plasma collections

  • 53 848

  • 40 348
  • 74.6% of target

  • 39 130

  • 72.6% of target

  • Covid-19 restrictions impact on collections

  • Focus on whole blood & PLCA collections

  • >=64 000

No. of source plasma collections

  • 53 848

  • 40 348
  • 74.6% of target

  • 39 130

  • 72.6% of target

  • Covid-19 restrictions impact on collections

  • Focus on whole blood & PLCA collections

  • >=64 000

Days’ cover (Group O Blood)

  • 4

  • 4.6

  • 4.1%

  • 5
  • Elective surgeries back to normal post Covid -  increasing demand
  • #MoreBlood initiative started, additional collection teams added to cover additional clinics to compensate for lower collection counts per clinic

Days’ cover (Group O Blood)

  • 4

  • 4.6

  • 4.1%

  • 5
  • Elective surgeries back to normal post Covid -  increasing demand
  • #MoreBlood initiative started, additional collection teams added to cover additional clinics to compensate for lower collection counts per clinic

#Of units of Apheresis platelets collected

  • 18 510

  • 18 148 

  • (target  was 16 280)

  • 19 627

  • >=20 000
  • Initiatives planned to cover country, marketing, medical, ops

#Of units of Apheresis platelets collected

  • 18 510

  • 18 148 

  • (target  was 16 280)

  • 19 627

  • >=20 000
  • Initiatives planned to cover country, marketing, medical, ops

% First time donors aged 16 – 30 years

  • >50%

  • 58%

  • 2021: Target was >70%

  • 69%

  •  >=50%
  • Specific initiatives to attract age group – eg airtime
  • Targeted donor gifting campaigns (FY22-23). Youth and general donor distinction

% First time donors aged 16 – 30 years

  • >50%

  • 58%

  • 2021: Target was >70%

  • 69%

  •  >=50%
  • Specific initiatives to attract age group – eg airtime
  • Targeted donor gifting campaigns (FY22-23). Youth and general donor distinction

Black donors as a percent of total donors

  • 37%

  • 45%
  • Pre Covid-19 target 46%

  • 39%
  • Target reduced to 37% (Covid-19 impacts)

  • >=37%
  • Campaigns to increase awareness
  • Increased and alternate collection facilities post Covid-19

Black donors as a percent of total donors

  • 37%

  • 45%
  • Pre Covid-19 target 46%

  • 39%
  • Target reduced to 37% (Covid-19 impacts)

  • >=37%
  • Campaigns to increase awareness
  • Increased and alternate collection facilities post Covid-19

Social media engagement

  • 20%

  • 51%

  • 26%

  • 95% of target
  • To aid the achievement of our plans to increase social engagement appointed a social media specialist and a senior marketing and communications manager

Social media engagement

  • 20%

  • 51%

  • 26%

  • 95% of target
  • To aid the achievement of our plans to increase social engagement appointed a social media specialist and a senior marketing and communications manager

Whole blood collection (Group O)

  • 473 452

  • 422 900
  • (target was 370 517)

  • 457 523
  • Covid-19 restrictions impact on collections

  • >=498 352
  • Minimise cutbacks
  • Campaigns in place and planned
  • Increase in staff #moreblood

Whole blood collection (Group O)

  • 473 452

  • 422 900
  • (target was 370 517)

  • 457 523
  • Covid-19 restrictions impact on collections

  • >=498 352
  • Minimise cutbacks
  • Campaigns in place and planned
  • Increase in staff #moreblood

NAVIGATE TO:

NAVIGATE TO:

How can we help you?

Let's Connect

Head Office

  • 1 Constantia Boulevard Constantia Kloof, Roodepoort, 1709
  • (011) 761-9000
  • customerservice@sanbs.org.za

Main Links

Ⓒ 2022 - All Rights Are Reserved. SANBS Integrated Report. Created by Joshero (Pty) Ltd.

Head Office

  • 1 Constantia Boulevard Constantia Kloof, Roodepoort, 1709
  • (011) 761-9000
  • customerservice@sanbs.org.za

Main Links

Ⓒ 2022 - All Rights Are Reserved. SANBS Integrated Report. Created by Joshero (Pty) Ltd.